<DOC>
	<DOCNO>NCT02486094</DOCNO>
	<brief_summary>This study test biopsy tissue patient treat primary rectal cancer Royal Marsden Hospital 2011 2013 , mrTRG score post-chemoradiotherapy MRI . It retrospective pilot study determine apoptotic proliferative index count pre post chemoradiotherapy .</brief_summary>
	<brief_title>Study PRoliferation Apoptosis Rectal Cancer , Predictive &amp; Prognostic biOmarkers : Histopathology Imaging</brief_title>
	<detailed_description>The investigator hope validate apoptotic proliferative index predictive response marker lend support mrTRG putative prognostic tool treatment pathway rectal cancer patient . Even though retrospective study , investigator hope pre-treatment apoptotic proliferative score correlate post treatment response mrTRG score . In , investigator predict patient respond treatment initial diagnostic biopsy foresee patient individual treatment plan .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<mesh_term>Rectal Diseases</mesh_term>
	<criteria>Patients 18 year age . Patients primary adenocarcinoma rectum ( diagnosed tissue biopsy disease spread assess CT MRI ) . Tumours must consider sufficiently highrisk require preoperative chemoradiotherapy follow surgery . Patients must pre posttreatment MRI scan rectum pelvis . We must access store tissue patient No preoperative radiotherapy Patients synchronous tumour Patients age 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Imaging , Magnetic Resonance</keyword>
	<keyword>Rectal Cancer</keyword>
	<keyword>Apoptosis</keyword>
	<keyword>Proliferation</keyword>
	<keyword>Cancer</keyword>
	<keyword>Tissue Study</keyword>
</DOC>